<DOC>
	<DOCNO>NCT00449592</DOCNO>
	<brief_summary>Zinc intracellular mineral important enzymatic cofactor activity cell membrane stability , DNA RNA structure . Zinc deficiency associate delay wound heal immune dysfunction . In patietns hematological malignancy inverse correlation find disease stage zinc level . Patients undergoing high dose chemotherapy hematologic malignancy predispose develop oral gastrointestinal complication , particular oral mucositis . These patient may relative zinc deficiency , therefore oral zinc therapy may benefical prevention complication .</brief_summary>
	<brief_title>Oral Zinc Therapy Prevention Mucositis</brief_title>
	<detailed_description>Patients candidate High dose chemotherapy stem cell support diagnosis relapsed/resistant Hodgkins NHL MM screen enrollment study . Patients randomize 1:1 ratio therapy either zincol 1 Tab TID placebo 1 Tab TID . Therapy start morning commence chemotherapy continue untill first either discharge day day 21 . Response assesment include : 1 . Mucositis assesment use NCI-CTC OMAS scores- do eod baseline untill day 21/discharge day day 21 2 . Evaluation zinc level serum , PBMC saliva- do baseline , day 6/7 day 21/discharge day day 21 . 3 . Collection clinical outcome data regard infectious complication including- presence length febrile neutropenia , use antibacterial antifungal medication ,</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Patients undergoing high dose chemotherapy stem cell support relapse resistant Hodgkins NHL ( treat BEAM protocol ) MM ( treat high dose melphalan ) . ECOG performance less equal 2 Adequate renal hepatic function Presence active malignancy BCC skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Stem cell transplantation</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Zinc</keyword>
</DOC>